16.04.2015 Views

ANNUAL REPORT 2012 - TiGenix

ANNUAL REPORT 2012 - TiGenix

ANNUAL REPORT 2012 - TiGenix

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

- Partnering of Cx601 (i.e. finding a<br />

partner for the co-development and/or<br />

commercialization of Cx601 in different<br />

regions); and<br />

- Monetizing of some assets, such as the<br />

Dutch manufacturing facility (which was<br />

constructed by the Company in a building<br />

leased under a long-term lease contract<br />

running until July 2029).<br />

continue the Company’s operations for the<br />

next twelve months.<br />

In accordance with Article 96, 6° of the<br />

Belgian Companies Code, taking into<br />

account two consecutive financial years of<br />

losses, the Board of Directors has decided,<br />

after consideration, to apply the valuation<br />

rules assuming “going concern”, for the<br />

reasons set out above.<br />

According to the budget, the effective and<br />

timely realization of the above assumptions<br />

of the action plan will generate sufficient<br />

additional cash to continue the Company’s<br />

operations during the next twelve months.<br />

However, at this moment it is uncertain<br />

whether the above assumptions will be<br />

realized timely. There is a risk that the action<br />

plan will not generate sufficient additional<br />

cash, as a result of the non-realization or only<br />

partly realization of one or more assumptions.<br />

There is also a risk that, even if most of<br />

the assumptions would be realized, this<br />

realization will happen too late, so that the<br />

necessary additional cash is not generated<br />

timely to continue the Company’s operations<br />

for the next twelve months.<br />

However, if the execution of the above action<br />

plan would not or not timely generate sufficient<br />

additional cash, the Board of Directors intends<br />

to explore the option of obtaining additional<br />

dilutive funding (i.e. a capital increase) or nondilutive<br />

funding.<br />

Notwithstanding the described uncertainties,<br />

the Board of Directors is confident that<br />

the action plan described above, in<br />

combination with, if needed, additional<br />

dilutive funding (i.e. a capital increase), will<br />

timely generate sufficient additional cash to<br />

Since the Company is currently able to satisfy<br />

all financial liabilities and is able to fulfil all<br />

payments, the Board of Directors is of the<br />

opinion that the continuity of the Company is<br />

not threatened.<br />

9. Conflicts of interest<br />

In <strong>2012</strong>, during 3 Board meetings, decisions<br />

were taken that required the application of<br />

the conflict of interests procedure pursuant<br />

to Article 523 of the Belgian Companies<br />

Code. The relevant parts of the minutes are<br />

copied below.<br />

Meeting of the Board of Directors<br />

of January 23, <strong>2012</strong><br />

“Introduction<br />

The chairman opened the meeting and<br />

explained that the board meeting was held<br />

at the request of Gil Beyen BVBA, represented<br />

by Gil Beyen.<br />

The latter has proposed to scale down its role<br />

in the Company to a half-time role, thereby<br />

permitting it to take up other commitments<br />

vis-à-vis other companies as well.<br />

Going forward, the main focus of Gil Beyen<br />

BVBA, represented by Gil Beyen, would be on :<br />

192 <strong>TiGenix</strong> I annual report <strong>2012</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!